Project Grant R56NS146980
- The National Institute of Neurological Disorders and Stroke awarded The Research Foundation For The State University Of New York (operating as Stony Brook University) $126,789 on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate the role of myocyte enhancer factor 2A (MEF2A) in the selective vulnerability of dopamine neurons in Parkinson's disease. The project examines molecular mechanisms underlying...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded The Research Foundation for the State University of New York $645,070 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research investigating mitochondrial gene regulation in central nervous system development, with focus on how the transcription...
- The National Institute of Neurological Disorders and Stroke awarded The Trustees of Columbia University in the City of New York $150,932 on March 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop computational and theoretical models characterizing interactions between motor cortex and dorsolateral striatum in naturalistic motor behavior. The project uses simultaneous multi-region neural recordings from mice combined...
- The National Institute of Neurological Disorders and Stroke awarded New York University $550,743 on August 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to fund research into the mechanisms of assembly of endocytic machinery at the periactive zone and its coupling to the presynaptic active zone. The research dissects how the large GTPase dynamin organizes both the active zone, where neurotransmitters are released from...
- The National Institute of Neurological Disorders and Stroke awarded The Regents of the University of California, San Francisco $595,208 on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853, Assistance Listing Project Grant R01NS148534). The award funds research investigating striatal synaptic plasticity mechanisms underlying cognitive dysfunction in Parkinson's disease. The project examines circuit- and synaptic-level...
- The National Institute of Neurological Disorders and Stroke awarded The Trustees of Columbia University in the City of New York $639,875 on August 10, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853, Assistance Listing Project Grant R01NS151292). The recipient will characterize the molecular steps that allow post-mitotic neurons to correctly integrate into neural circuits, focusing on motor neurons that target adult leg muscles in...
- The National Institute of General Medical Sciences awarded The Research Foundation For The State University Of New York (Stony Brook University) $432,569 on March 5, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the regulatory mechanisms of extracellular particle-mediated intercellular signaling. The research deciphers how cells release extracellular particles containing biomolecules to establish non-contact communication with neighboring or...
- The National Institute of Neurological Disorders and Stroke awarded The Trustees of Columbia University in the City of New York $126,900 on March 7, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research to exploit RNA biogenesis, specifically alternative splicing programs, to accelerate maturation of human neurons in vitro and to develop models of age-related tauopathies. The research addresses a fundamental...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded $627,103 to the Research Foundation For Mental Hygiene, Inc. on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The Research Foundation For Mental Hygiene, Inc., operating through its New York State Psychiatric Institute division, will investigate the role of the adaptive...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $470,293 to The Research Foundation For The State University of New York (SUNY at Binghamton) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 1, 2025, through June 30, 2027. This Project Grant funds research aimed at identifying and characterizing the electrophysiological features of spinal motor neurons during...
The National Institute of Neurological Disorders and Stroke awarded The Research Foundation For The State University Of New York (operating as Stony Brook University) $552,680 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds investigation of disrupted striatal cholinergic signaling and compulsive motor behaviors. The research tests a hypothesis that impaired striatal cholinergic signaling promotes pathway-specific changes in dorsal striatal spiny projection neurons that bias striatal activity toward the direct pathway and promote compulsive motor behaviors. Work will employ two-photon laser scanning microscopy, genetically encoded acetylcholine sensors, slice electrophysiology, optogenetics, and in vivo fiber photometry across three specific aims. Experiments will be conducted on two mouse models of compulsive motor behavior: SAPAP3 and SLITRK5 null mice. The research addresses compulsive motor behaviors—repetitive, stereotyped, insuppressible behaviors—that are common comorbid motor symptoms in striatum-based disorders affecting over 1 percent of the population, and for which treatment options are limited due to insufficient understanding of underlying brain circuits and lack of explicit therapeutic targets. Performance takes place in Stony Brook, New York. The period of performance runs from September 1, 2026, through August 31, 2027. The assistance type is a Project Grant. The Research Foundation For The State University Of New York, the parent entity administering the award, is a nonprofit research foundation serving as the fiscal and administrative agent for SUNY institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $552.7k | 8/28/26 |